Linden Advisors LP Takes Position in Oaktree Acquisition Corp. III Life Sciences $OACC

Key Points

• Linden Advisors LP acquired 600,000 shares of Oaktree Acquisition Corp. III Life Sciences, worth approximately $6,120,000, representing about 2.68% of the company.
• Other institutional investors, including Kepos Capital LP and Mizuho Securities USA LLC, have also recently invested in Oaktree Acquisition Corp. III Life Sciences during the first quarter.
• The stock of Oaktree Acquisition Corp. III Life Sciences opened at $10.44 and has ranged between a 12-month low of $9.95 and a high of $10.85.

Linden Advisors LP purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) in the first quarter, according to its most recent filing with the SEC. The firm purchased 600,000 shares of the company's stock, valued at approximately $6,120,000. Linden Advisors LP owned 2.68% of Oaktree Acquisition Corp. III Life Sciences at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of OACC. AQR Arbitrage LLC acquired a new stake in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth about $19,743,000. Toronto Dominion Bank acquired a new stake in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth about $14,355,000. Driehaus Capital Management LLC acquired a new stake in Oaktree Acquisition Corp. III Life Sciences during the 1st quarter worth about $9,180,000. Two Sigma Investments LP acquired a new stake in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth about $4,358,000. Finally, Lighthouse Investment Partners LLC acquired a new stake in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter worth about $3,039,000.

Oaktree Acquisition Corp. III Life Sciences Stock Performance

Oaktree Acquisition Corp. III Life Sciences stock remained flat at $10.44 during trading hours on Wednesday. The company's stock had a trading volume of 71,513 shares, compared to its average volume of 100,331. The stock's fifty day moving average price is $10.44 and its 200 day moving average price is $10.33. Oaktree Acquisition Corp. III Life Sciences has a 52-week low of $9.95 and a 52-week high of $10.85.

About Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.